SecBot SecBot
EFFECT ·Filed Mar 11, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed8mo ago SEC9999999995-26-000767
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future prospectus supplements that will disclose actual offering size, pricing, and use of proceeds. The effectiveness of the S-3 enables flexible capital raising, which could lead to near-term dilution if shares are issued.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.96
T+0 close · Mar 11, 2026 · via day close
Latest settled
−41.13%
T+60 · $2.92
Vs SPY
−52.65%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 11 $4.96entry
  2. T+1 · 8mo ago −0.81%α +0.68% · $4.92
  3. T+5 · 8mo ago −9.88%α −7.69% · $4.47
  4. T+20 · 7mo ago −27.42%α −27.94% · $3.60
  5. T+60 · 6mo ago −41.13%α −52.65% · $2.92
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Rocket Pharmaceuticals, Inc. has an effective shelf registration (Form S-3) as of March 10, 2026, allowing the company to issue unspecified securities from time to time. This creates a potential for future dilution, though no specific offering size or terms were disclosed.

Key Facts

  • Form S-3 shelf registration became effective on March 10, 2026.
  • The filing is a general offering statement, permitting the company to sell securities in one or more offerings without filing a new registration.
  • No specific offering size, pricing, or use of proceeds was disclosed in this filing.
  • The company may issue common stock, preferred stock, debt, or warrants under this shelf.

Financial Impact

Not specified

dilutionequitydebt

Risk Factors

  • Potential for unexpected equity issuance leading to shareholder dilution.
  • Market perception of a dilution overhang may pressure the stock price ahead of any offering.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000767
Document: 9999999995-26-000767-index.html9999999995-26-000767
Document: 9999999995-26-000767.txt9999999995-26-000767

US Market Status

Market Closed · Opens in 6h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 11, 2026